• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Arteris Inc.

    11/13/24 4:32:26 PM ET
    $AIP
    Semiconductors
    Technology
    Get the next $AIP alert in real time by email
    SC 13G/A 1 d294128dsc13ga.htm SC 13G/A SC 13G/A

     

     

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    Schedule 13G

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 3)*

     

     

    Arteris, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    04302A104

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 04302A104    Schedule 13G    Page 1 of 4

     

     1   

     Names of Reporting Persons

     

     Ventech Capital F

     2  

     Check the Appropriate Box if a Member of a Group

     (a) ☐  (b) ☐

     

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     France

    Number of

    Shares

    Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

     Sole Voting Power

     

     1,472,151

       6   

     Shared Voting Power

     

     0

       7   

     Sole Dispositive Power

     

     1,472,151

       8   

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     1,472,151

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     3.8%

    12  

     Type of Reporting Person

     

     FI


    CUSIP No. 04302A104    Schedule 13G    Page 2 of 4

     

    ITEM 1. (a)

    Name of Issuer:

    Arteris, Inc. (the “Issuer”).

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    900 E. Hamilton Ave., Suite 300, Campbell, CA 95008

     

    ITEM 2. (a)

    Name of Person Filing:

    This statement is filed on behalf of Ventech Capital F (the “Reporting Person”).

     

      (b)

    Address or Principal Business Office:

    The business address of the Reporting Person is 47 Avenue de l’Opéra, Paris 75002, France.

     

      (c)

    Citizenship of each Reporting Person is:

    Ventech Capital F is organized under the laws of France.

     

      (d)

    Title of Class of Securities:

    Common Stock, par value $0.001 per share (“Common Stock”).

     

      (e)

    CUSIP Number:

    04302A104

     

    ITEM 3.

    Not applicable.


    CUSIP No. 04302A104    Schedule 13G    Page 3 of 4

     

    ITEM 4.

    Ownership.

    (a-c)

    The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of September 30, 2024, based upon 39,257,166 shares of Common Stock outstanding as of July 25, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 1, 2024.

     

    Reporting Person   

    Amount

    beneficially

    owned

        

    Percent

    of class:

        Sole power
    to vote or
    to direct
    the vote:
         Shared power
    to vote or to
    direct the
    vote:
        

    Sole

    power to
    dispose or
    to direct
    the
    disposition

    of:

        

    Shared

    power to

    dispose or

    to direct

    the

    disposition

    of:

     

    Ventech Capital F

         1,472,151        3.8 %      1,472,151        0        1,472,151        0  

    The Reporting Person is the record holder of 1,472,151 shares of Common Stock.

     

    ITEM 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owners of more than five percent of the class of securities, check the following: ☒

     

    ITEM 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    ITEM 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

     

    ITEM 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    ITEM 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    ITEM 10.

    Certification.

    Not applicable.


    CUSIP No. 04302A104    Schedule 13G    Page 4 of 4

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: November 13, 2024

     

    Ventech Capital F
    By:  

    /s/ Christian Claussen

    Name:   Christian Claussen
    Title:   General Partner
    Get the next $AIP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AIP

    DatePrice TargetRatingAnalyst
    9/1/2023$11.00 → $12.00Outperform
    TD Cowen
    3/4/2022$32.00 → $23.00Outperform
    Cowen
    11/22/2021$27.00Outperform
    Northland Capital
    11/22/2021$24.00Market Perform
    BMO Capital Markets
    11/22/2021$30.00Outperform
    Cowen
    11/22/2021$33.00Buy
    Jefferies
    11/22/2021$35.00Buy
    Rosenblatt
    More analyst ratings